Phase II, multicentre, randomised, double-blind, placebo-controlled, pilot study to determine the efficacy, safety, tolerability and pharmacokinetics of intravesical PSD597 [lidocaine] in reducing the pain of the bladder biopsy procedure

Trial Profile

Phase II, multicentre, randomised, double-blind, placebo-controlled, pilot study to determine the efficacy, safety, tolerability and pharmacokinetics of intravesical PSD597 [lidocaine] in reducing the pain of the bladder biopsy procedure

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2007

At a glance

  • Drugs Lidocaine (Primary)
  • Indications Procedural pain
  • Focus Therapeutic Use
  • Sponsors Plethora Solutions
  • Most Recent Events

    • 17 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top